Vasospastic angina in women: Clinical backgrounds and prognoses of patients younger than and older than 60 years

Table 3 Echographic parameters in the two groups

			Group O	Group Y	P value
UCG
LVEF (%)			68 ± 9	66 ± 6	0.46
Brachial ultrasonography
All studied patients
	No.		77	17
	Heart rate (/min)		66 ± 10	67 ± 13	0.85
	Mean blood pressure		100 ± 14	94 ± 14	0.16
	Brachial blood flow
		Baseline (mL/min)	61 ± 44	59 ± 52	0.87
		% increase	384 ± 490	327 ± 265	0.59
	Brachial artery diameter (mm)
		Baseline	3.5 ± 0.5	3.5 ± 0.5	0.83
		Hyperemia	3.7 ± 0.5	3.6 ± 0.5	0.88
		After NTG	4.0 ± 0.5	4.2 ± 0.4	0.25
	FMD (%)		4.3 ± 3.2	4.5 ± 3.3	0.75
	NID (%)		13.6 ± 5.4	20.5 ± 8.6	< 0.01
Patients who did not take any coronary vasodilators
	No.		39	14
	Brachial artery diameter (mm)
		Baseline	3.5 ± 0.5	3.6 ± 0.4	0.68
		Hyperemia	3.6 ± 0.6	3.7 ± 0.4	0.60
		After NTG	4.0 ± 0.5	4.2 ± 0.4	0.21
	FMD (%)		4.1 ± 3.1	4.3 ± 3.5	0.82
	NID (%)		14.6 ± 5.7	18.5 ± 6.5	0.04

FMD: Flow-mediated dilation; LVEF: Left ventricular ejection fraction; NID: Nitroglycerin-induced dilation; NTG: Nitroglycerin; No.: Number; UCG: Echocardiography; Group O: Older than 60 years of age; Group Y: Younger than 60 years of age.